Pulmonary Function Tests (PFTs) are key diagnostic tools in respiratory medicine, providing valuable insights into the functional status of the lungs. However, their interpretation can be complex and daunting for healthcare professionals. This article aims to simplify the understanding of PFTs and enhance their practical application.
Spirometry measures the amount (volume) and the speed (flow) of air that can be inhaled and exhaled. Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in the first second (FEV1), and their ratio (FEV1/FVC), which are essential in diagnosing obstructive and restrictive lung diseases.
These tests measure the capacity of the lungs to transfer gas from inhaled air to the red blood cells. The most common is the Diffusing capacity of the Lung for Carbon Monoxide (DLCO). Decreased DLCO may indicate conditions like pulmonary fibrosis or emphysema.
These tests provide information about the size of the lungs and the resistance to airflow in the bronchial tubes. They can be useful in diagnosing conditions like asthma and chronic obstructive pulmonary disease (COPD).
These tests measure lung function during physical activity. They can help identify exercise-induced bronchospasm, unexplained dyspnea, and assess suitability for lung surgery.
Interpreting PFTs is a critical skill for healthcare professionals involved in respiratory care. By understanding the various components of PFTs, clinicians can make accurate diagnoses, monitor disease progression, and guide therapeutic decisions. Continuous education and practice are key to mastering this essential tool in pulmonary medicine.
1.
The Clues Hidden in Failed Prostate Cancer Trials
2.
Updates from the 2022 WHO classification of kidney epithelial tumors
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
We Don't Always Know What's 'Best' for Our Patients
5.
Conditional EU Nod for Weekly Pill in Pediatric Glioma
1.
AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence
2.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
3.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
4.
Contemporary Frameworks in Oncology Across Clinical Settings
5.
Unlocking the Immune Arsenal: A Revolution in Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Efficient Management of First line ALK-rearranged NSCLC - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation